These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7160202)
1. Treatment of the sexually dangerous patient. Kelly JR; Cavanaugh JL Curr Psychiatr Ther; 1982; 21():101-13. PubMed ID: 7160202 [No Abstract] [Full Text] [Related]
2. Legal and ethical issues in the use of antiandrogens in treating sex offenders. Melella JT; Travin S; Cullen K Bull Am Acad Psychiatry Law; 1989; 17(3):223-32. PubMed ID: 2529005 [TBL] [Abstract][Full Text] [Related]
3. The paraphilias and Depo-Provera: some medical, ethical and legal considerations. Berlin FS Bull Am Acad Psychiatry Law; 1989; 17(3):233-9. PubMed ID: 2529006 [TBL] [Abstract][Full Text] [Related]
4. The therapeutic use of androgen-depleting hormone. Money J Int Psychiatry Clin; 1971; 8(4):165-74. PubMed ID: 5155162 [No Abstract] [Full Text] [Related]
5. [Clinical use of antiandrogens in psychiatry]. Hoffet H Gynakologe; 1980 Mar; 13(1):33-43. PubMed ID: 6219928 [No Abstract] [Full Text] [Related]
6. Policing "perversions": Depo-Provera and John Money's new sexual order. Tsang DC J Homosex; 1995; 28(3-4):397-426. PubMed ID: 7560938 [TBL] [Abstract][Full Text] [Related]
7. Sex hormones, neurotransmitters, and psychopharmacological treatments in men with paraphilic disorders. Saleh FM; Berlin FS J Child Sex Abus; 2003; 12(3-4):233-53. PubMed ID: 15308453 [TBL] [Abstract][Full Text] [Related]
8. Commentary on antiandrogenic treatment in a university setting. Barry DJ J Am Coll Health; 1987 May; 35(6):275-6. PubMed ID: 3584711 [No Abstract] [Full Text] [Related]
9. [Treatment of sex offenses with antiandrogens]. Kockott G Psychiatr Prax; 1983 Sep; 10(5):158-64. PubMed ID: 6227026 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of sex offenders with leuprorelin]. Nøttestad JA; Bjarnar E; Lundmo PI; Sandvik M Tidsskr Nor Laegeforen; 2006 Feb; 126(5):633-4. PubMed ID: 16505878 [No Abstract] [Full Text] [Related]
11. Use of depo-provera in the treatment of aggressive sexual offenders: preliminary report of three cases. Barry DJ; Ciccone JR Bull Am Acad Psychiatry Law; 1975; 3(3):179-84. PubMed ID: 1230194 [TBL] [Abstract][Full Text] [Related]
12. The hormonal treatment of sexual offenders. Bradford JM Bull Am Acad Psychiatry Law; 1983; 11(2):159-69. PubMed ID: 6225477 [No Abstract] [Full Text] [Related]
13. Treatment outcomes of chemical castration on Korean sex offenders. Koo KC; Shim GS; Park HH; Rha KH; Choi YD; Chung BH; Hong SJ; Lee JW J Forensic Leg Med; 2013 Aug; 20(6):563-6. PubMed ID: 23910832 [TBL] [Abstract][Full Text] [Related]
14. Risk/benefit ratio of androgen deprivation treatment for sex offenders. Berlin FS J Am Acad Psychiatry Law; 2009; 37(1):59-62. PubMed ID: 19297635 [TBL] [Abstract][Full Text] [Related]
15. Drug treatment of paraphilic and nonparaphilic sexual disorders. Guay DR Clin Ther; 2009 Jan; 31(1):1-31. PubMed ID: 19243704 [TBL] [Abstract][Full Text] [Related]
16. Protocols for the use of cyproterone, medroxyprogesterone, and leuprolide in the treatment of paraphilia. Reilly DR; Delva NJ; Hudson RW Can J Psychiatry; 2000 Aug; 45(6):559-63. PubMed ID: 10986575 [TBL] [Abstract][Full Text] [Related]
18. A hypersexual paraphilic patient treated with leuprolide acetate: a single case report. Saleh F J Sex Marital Ther; 2005; 31(5):433-44. PubMed ID: 16169826 [TBL] [Abstract][Full Text] [Related]
19. Satyriasis: a case study. Moore SL J Clin Psychiatry; 1980 Aug; 41(8):279-81. PubMed ID: 7400106 [TBL] [Abstract][Full Text] [Related]
20. [Therapy of sex-drive abnormalities in medical practice]. Tessmann R Med Welt; 1972 Feb; 23(6):188-91. PubMed ID: 5062181 [No Abstract] [Full Text] [Related] [Next] [New Search]